Evgen Pharma

company

About

Evgen Pharma is a clinical stage drug development company focused on the treatment of cancer and neurological conditions

  • 1 - 10

Details

Last Funding Type
Series A
Industries
Biotechnology,Medical,Pharmaceutical
Founded date
Jan 1, 2007
Number Of Employee
1 - 10
Operating Status
Active

Evgen Pharma is a clinical stage drug development company focused on the treatment of cancer and neurological conditions. Evgen’s pipeline is based on our proprietary Sulforadex® technology, and includes a number of synthetic, stabilised analogues of the naturally occurring compound sulforaphane. Many peer-reviewed scientific papers have identified the medical potential of sulforaphane in multiple indications. Our objective is to use our Sulforadex® technology to turn this scientific promise into commercially successful products.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
£460K
Evgen Pharma has raised a total of £460K in funding over 2 rounds. Their latest funding was raised on Jul 25, 2012 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 25, 2012 Series Unknown £460K 1 Detail
Sep 20, 2011 Series A 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
Evgen Pharma is funded by 2 investors. Sarum Partners and Rising Stars Growth Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Sarum Partners Series Unknown
Rising Stars Growth Fund Series A